News
Cigna's pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.
Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...
According to a study funded by Eli Lilly, the trial revealed that participants taking tirzepatide, the drug sold as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results